Open AccessThe study of risk in pulmonary arterial hypertension
Author(s) -
Lewis J. Rubin,
Gérald Simonneau,
David B. Badesch,
Nazzareno Galiè,
Marc Humbert,
Anne Keogh,
Joseph Massaro,
Marco Matucci Cerinic,
Olivier Sitbon,
Steven Kymes
Publication year - 2012
Publication title -
european respiratory review
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.565
H-Index - 66
eISSN - 1600-0617
pISSN - 0905-9180
DOI - 10.1183/09059180.00003712
Subject(s) - medicine , reimbursement , pulmonary hypertension , intensive care medicine , clinical trial , arterial wall , disease , health care , economics , economic growth
A growing body of published evidence exists on the risk factors for disease progression in pulmonary arterial hypertension (PAH). The Scientific Steering Committee for the Study of Risk in PAH was established to bring together leading clinical and statistical experts in PAH and risk modelling, for the purpose of advancing the understanding of the risk of development and progression of PAH. Herein, we discuss the impact of this information on three key areas: 1) clinical decision-making; 2) policy and reimbursement; and 3) future trials and research.